Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

Novartis Investigative Site, Melbourne

Novartis Investigative Site, Plovdiv

Novartis Investigative Site, Debrecen

Novartis Investigative Site, Adelaide

Novartis Investigative Site, Murdoch

Novartis Investigative Site, Zurich

Novartis Investigative Site, Varna

Weill Cornell Medicine NY-Presb, New York

Memorial Sloan Kettering Cancer Ctr, New York

Novartis Investigative Site, Belgrade

Novartis Investigative Site, Riyadh

Novartis Investigative Site, Uijeongbu-si

Novartis Investigative Site, Marseille

Novartis Investigative Site, Berlin

Roswell Park Cancer Institute, Buffalo

Novartis Investigative Site, Milan

Sidney Kimmel Comprehensive Cancer Center, Baltimore

Novartis Investigative Site, Kiel

Novartis Investigative Site, Madrid

Novartis Investigative Site, Bordeaux

Novartis Investigative Site, Istanbul

Novartis Investigative Site, Istanbul

Novartis Investigative Site, Izmir

Novartis Investigative Site, Düsseldorf

Novartis Investigative Site, Toledo

Indiana Blood and Marrow Institute, Beech Grove

Novartis Investigative Site, Bilbao

University of Michigan Clinical Trials Office, Ann Arbor

Novartis Investigative Site, Busan

Novartis Investigative Site, Vandœuvre-lès-Nancy

Novartis Investigative Site, Samsun

Novartis Investigative Site, Frankfurt am Main

University of Chicago Hospital, Chicago

Novartis Investigative Site, Monterrey

Novartis Investigative Site, Mannheim

Novartis Investigative Site, Heidelberg

Novartis Investigative Site, Lyon

Novartis Investigative Site, Bari

Novartis Investigative Site, Paris

Uni Of TX MD Anderson Cancer Cntr, Houston

Novartis Investigative Site, Napoli

Utah Huntsman Cancer Center, Salt Lake City

Novartis Investigative Site, Moscow

Novartis Investigative Site, Moscow

Novartis Investigative Site, El Achrafiyé

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Timișoara

Novartis Investigative Site, Novi Sad

Novartis Investigative Site, Cluj-Napoca

Novartis Investigative Site, Jeollanam

Novartis Investigative Site, Ẕerifin

Novartis Investigative Site, Jerusalem

Dana Farber Cancer Center, Boston

Novartis Investigative Site, CABA

Novartis Investigative Site, Capital Federal

Novartis Investigative Site, Córdoba

Novartis Investigative Site, Rio de Janeiro

Novartis Investigative Site, São Paulo

Novartis Investigative Site, São Paulo

Novartis Investigative Site, Porto Alegre

Novartis Investigative Site, Toronto

Novartis Investigative Site, Ostrava

Novartis Investigative Site, Brno Bohunice

Novartis Investigative Site, Jena

Novartis Investigative Site, Budapest

Novartis Investigative Site, Nagoya

Novartis Investigative Site, Toyoake

Novartis Investigative Site, Kashiwa

Novartis Investigative Site, Ōsaka-sayama

Novartis Investigative Site, Suita

Novartis Investigative Site, Bunkyo Ku

Novartis Investigative Site, Chūō

Novartis Investigative Site, Akita

Novartis Investigative Site, Aomori

Novartis Investigative Site, Kobe

Novartis Investigative Site, Beirut

Novartis Investigative Site, Amsterdam

Novartis Investigative Site, Dordrecht

Novartis Investigative Site, Seoul

Novartis Investigative Site, Barcelona

Novartis Investigative Site, L'Hospitalet de Llobregat

Novartis Investigative Site, Adana

Novartis Investigative Site, Cardiff

Novartis Investigative Site, Glasgow

Novartis Investigative Site, Liverpool

Novartis Investigative Site, London

Novartis Investigative Site, Oxford